Goldlust, S. A., Badruddoja, M. A., Blondin, N. A., Peters, K. B., Wagle, N., Stea, B., Newton, H. B., Cohen, A. L., Goldin, C., Kong, X., Aiken, R., Tsung, A., Mahadevan, D., Huang, C., Unger, E. C. (2026). A phase 2 double-blind, randomized, prospective, placebo-controlled study of NanO₂ combined with radiation and temozolomide in patients with newly diagnosed glioblastoma: RESTORE.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2065